Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
Cellular & Molecular Immunology|August 9, 2011
Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapyThanh-Nhan Nguyen-Pham, Deok-Hwan Yang, Truc-Anh Thi Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligandsHyeung-Geun Park, Ji-Yeon Choi, Mi-Hyun Kim, et al.
Anticancer Research|February 27, 2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South KoreaMi-Hyun Kim, Chang Min Choi, Sung Yong Lee, et al.
Cancers|September 28, 2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic StrategiesYoungtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, et al.
Cancer Medicine|July 14, 2021
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South KoreaTaeyun Kim, Tae Won Jang, Chang Min Choi, et al.
Cancer Research and Treatment|May 23, 2023
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET StudyTaeyun Kim, Tae Won Jang, Chang Min Choi, et al.
Journal of Medicinal Chemistry|December 18, 2023
Degradation of Polo-like Kinase 1 by the Novel Poly-Arginine N-Degron Pathway PROTAC Regulates Tumor Growth in Nonsmall Cell Lung CancerPethaiah Gunasekaran, Yeon Sil Hwang, Gong-Hyeon Lee, et al.
Translational Lung Cancer Research|July 10, 2023
Real-world analysis of first-line afatinib in patients with <i>EGFR</i>-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factorsJehun Kim, Tae Won Jang, Chang Min Choi, et al.
Frontiers in Immunology|April 29, 2024
Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer typesDong Kwon Kim, Chai Young Lee, Yu Jin Han, et al.
Thoracic Cancer|April 4, 2017
Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter studyWon Kee Lee, Shin Yup Lee, Jin Eun Choi, et al.
Pageof 37